GE HealthCare (GEHC) Stock Price, Fundamentals & Analysis

What GEHC does

GE HealthCare (GEHC) is a stock in the Healthcare sector, operating in the Medical Devices industry. Headquartered in Chicago, United States, the company develops, manufactures, and markets products and digital solutions used in the diagnosis, treatment, and monitoring of patients. It operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The company is part of the S&P 500.

Key numbers explained

• GE HealthCare trades at 66.09 USD, with a trailing P/E ratio of 15.2 and a forward P/E ratio of 12.2, which compare its share price to recent and expected earnings.
• The dividend yield is 0.21%, meaning the annual dividend represents 0.21% of the current share price, with 3% of earnings paid out as dividends.
• Market capitalisation stands at 30.06B USD, reflecting the total market value of all outstanding shares.
• Beta is 0.82, indicating the stock has historically been less volatile than the overall market.
• Return on equity is 19.4%, showing how effectively the company generates profit from shareholders' equity.
• Revenue for the trailing 12 months is 21.27B USD, growing 5.8% year over year, with a profit margin of 9.3% and an operating margin of 15%.
• The price-to-book ratio is 2.72, comparing the market price to the company's book value per share.
• The debt-to-equity ratio is 94%, indicating the level of debt relative to shareholders' equity.

Recent news

Recent headlines note that GE HealthCare is down significantly and some analysts see a potential turnaround. The company appointed AT&T CFO Pascal Desroches to its Board of Directors and announced a cash dividend increase for the third quarter of 2026.

What to watch

Investors typically monitor the healthcare sector and medical devices industry for regulatory changes, technological innovation, and reimbursement policy shifts. Earnings reports, such as the upcoming release on Oct 28, 2026, can drive short-term price movements. Broader market conditions and comparisons with peers like Bristol Myers Squibb (BMY), Thermo Fisher Scientific (TMO), and Mettler Toledo (MTD) may also influence sentiment.